Antares Pharma Inc. (AIS) SEC Filings - Page 1

SEC Filings for Antares Pharma Inc. (AIS) 
$ 2.59   -0.09 (-3.36%) Volume: 1.26 m 4:00 PM EST Feb 10, 2012
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KReport of unscheduled material events or corporate changes.302/10/2012
   
8-KReport of unscheduled material events or corporate changes.402/08/2012
   
8-KReport of unscheduled material events or corporate changes.601/26/2012
   
CT ORDER101/05/2012
   
8-KReport of unscheduled material events or corporate changes.2301/03/2012
   
4Statement of changes in beneficial ownership of securities112/22/2011
   
424B3Prospectus filed under Rule 424(b)(3)212/14/2011
   
8-KReport of unscheduled material events or corporate changes.312/09/2011
   
8-KReport of unscheduled material events or corporate changes.3411/15/2011
   
10-QQuarterly report with a continuing view of a company's financial position3711/14/2011
   
10-QQuarterly report with a continuing view of a company's financial position3011/08/2011
   
8-KReport of unscheduled material events or corporate changes.309/15/2011
   
4Statement of changes in beneficial ownership of securities109/13/2011
   
4Statement of changes in beneficial ownership of securities109/13/2011
   
4Statement of changes in beneficial ownership of securities109/13/2011
   
<<
First
<
Prev
123456789101112131415